Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  

Shinya Goto

Alejandro González Veliz: Can Factor XIa Inhibition Prevent Recurrent Ischemic Events Without Increasing Bleeding?
Oct 25, 2026, 14:16 | Voices
Alejandro González Veliz: Can Factor XIa Inhibition Prevent Recurrent Ischemic Events Without Increasing Bleeding?
Alejandro González Veliz, Interventional Cardiologist at Institute of Cardiology and Cardiovascular Surgery, shared a post…
Wolfgang Miesbach: Milvexian After Acute Coronary Syndrome - What LIBREXIA ACS Found
Oct 8, 2026, 11:45 | Science
Wolfgang Miesbach: Milvexian After Acute Coronary Syndrome - What LIBREXIA ACS Found
Wolfgang Miesbach, Head of Hemostasis/Hemophilia Center at Medical Clinic 2 at University Hospital Frankfurt, shared…
Shinya Goto: DOAC vs Placebo in Intermediate Stroke Risk of AF in Single Country?
Sep 25, 2026, 19:49 | Science
Shinya Goto: DOAC vs Placebo in Intermediate Stroke Risk of AF in Single Country?
Shinya Goto, Director and Chairman in Metabolic Disease Research Center, shared a post on LinkedIn…
Shinya Goto: Country Specific Randomized Trial Show the Merit of DOAC in Intermediate Risk of A
Sep 15, 2026, 01:58 | Science
Shinya Goto: Country Specific Randomized Trial Show the Merit of DOAC in Intermediate Risk of A
Shinya Goto, Director and Chairman in Metabolic Disease Research Center, shared a post on LinkedIn…
Shinya Goto: Targeted Thrombolysis for High Risk Pulmonary Embolism
Sep 5, 2026, 05:11 | Science
Shinya Goto: Targeted Thrombolysis for High Risk Pulmonary Embolism
Shinya Goto, Director and Chairman in Metabolic Disease Research Center, shared a post on LinkedIn about a recent…
Shinya Goto: When Cardiovascular Risk Gets Lower, RCTs Get Harder
Sep 4, 2026, 17:28 | Science
Shinya Goto: When Cardiovascular Risk Gets Lower, RCTs Get Harder
Shinya Goto, Director and Chairman in Metabolic Disease Research Center, shared a post on LinkedIn…
Kemal Karaagac: Milvexian Did Not Reduce Ischemic Events but Did Not Increase Fatal Bleeding
Aug 31, 2026, 16:55 | Science
Kemal Karaagac: Milvexian Did Not Reduce Ischemic Events but Did Not Increase Fatal Bleeding
Kemal Karaagac, Cardiologist at Cihangir Hospital, shared a post on X about a recent article by…
Shinya Goto: DOACs Across Populations Through Patient-Level Evidence
Jul 29, 2026, 11:24 | Science
Shinya Goto: DOACs Across Populations Through Patient-Level Evidence
Shinya Goto, Director and Chairman in Metabolic Disease Research Center, shared a post on LinkedIn…
Shinya Goto: JCS/JPCPHS 2025 Guideline Now Available in English
Jul 21, 2026, 19:44 | Science
Shinya Goto: JCS/JPCPHS 2025 Guideline Now Available in English
Shinya Goto, Director and Chairman in Metabolic Disease Research Center, shared a post on LinkedIn…
Heghine Khachatryan: How Well Do We Recognize Anti-PF4 Disorders?
Jul 20, 2026, 14:33 | Science
Heghine Khachatryan: How Well Do We Recognize Anti-PF4 Disorders?
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology…
Shinya Goto: Short-Course Rivaroxaban, Then Aspirin for Post-Arthroplasty VTE Prevention
Jul 19, 2026, 15:50 | Science
Shinya Goto: Short-Course Rivaroxaban, Then Aspirin for Post-Arthroplasty VTE Prevention
Shinya Goto, Director and Chairman in Metabolic Disease Research Center, shared a post on LinkedIn about a…
Shinya Goto: Extended DAPT with Aspirin/Clopidogrel Brought Better Efficacy Results in Complex, but Stable CAD patients!
Jul 17, 2026, 09:01 | Science
Shinya Goto: Extended DAPT with Aspirin/Clopidogrel Brought Better Efficacy Results in Complex, but Stable CAD patients!
Shinya Goto, Director and Chairman in Metabolic Disease Research Center, shared a post on LinkedIn…
Shinya Goto: How Newton’s Laws Shape Platelet Function
Jun 26, 2026, 05:55 | Science
Shinya Goto: How Newton’s Laws Shape Platelet Function
Shinya Goto, Director and Chairman in Metabolic Disease Research Center, shared a post on LinkedIn about…
Shinya Goto: The Japanese Investigators Behind Tranexamic Acid
Jun 12, 2026, 16:11 | Science
Shinya Goto: The Japanese Investigators Behind Tranexamic Acid
Shinya Goto, Director and Chairman in Metabolic Disease Research Center, shared a post on LinkedIn…
Jean Connors: Discussing Cancer-Associated Thrombosis at the Japanese Society of Thrombosis and Hemostasis
Jun 3, 2026, 16:59 | Voices
Jean Connors: Discussing Cancer-Associated Thrombosis at the Japanese Society of Thrombosis and Hemostasis
Jean Connors, Chief of Cancer Hematology at Dana-Farber Cancer Institute, posted on LinkedIn: ''Honored to be invited…
Mattia Galli: It Is Time to Recognize Ethnic Differences in Antithrombotic Therapy
May 3, 2026, 04:45 | Science
Mattia Galli: It Is Time to Recognize Ethnic Differences in Antithrombotic Therapy
Mattia Galli, Assistant Professor at Sapienza University of Rome, Associate Editor of European Heart Journal,…
Shinya Goto։ New Lancet Meta-Analysis on Statin-Related Adverse Effects
Feb 8, 2026, 13:45 | Science
Shinya Goto։ New Lancet Meta-Analysis on Statin-Related Adverse Effects
Shinya Goto, Director and Chairman in Metabolic Disease Research Center, shared a post on LinkedIn about a…
Shinya Goto: Another Important ABC Risk Score for AF Paper
Feb 6, 2026, 19:05 | Voices
Shinya Goto: Another Important ABC Risk Score for AF Paper
Shinya Goto, Director and Chairman in Metabolic Disease Research Center, shared a post on LinkedIn…
GARFIELD-VTE Registry: Important Insights on Sex Differences in VTE Outcomes
Aug 31, 2025, 07:08 | Science
GARFIELD-VTE Registry: Important Insights on Sex Differences in VTE Outcomes
Shinya Goto, Director and Chairman, Metabolic Disease Research Center at Tokai University, shared an informative…
All: 19 Posts: 1 - 100
NewsFeed